Drugs / MNCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02662400 | Jan → Oct 2016 | type 2 diabetes mellitus | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02662400 ↗ |
| Modality | Cell therapy | “autologous bone marrow - derived stem cell transplantation” NCT02662400 ↗ |
| Route | Other | “injected into superior pancreatico duodenal artery” NCT02662400 ↗ |